Postdoctoral Training Opportunity - Scleroderma
A postdoctoral position is available in the Scleroderma Research Laboratory to investigate the pathogenesis and treatment of organ fibrosis, focusing on skin, lung and muscle fibrosis. Experimental approaches use mouse disease models, transgenic animals, human disease samples, and cell lines. They study immunological, metabolic and cellular alterations underlying scleroderma and related orphan diseases with the goal of discovering novel targets, biomarkers and therapies. The laboratory work is closely integrated with their clinical research and innovative human trials. The lab uses cellular and in vivo mouse imaging, ex vivo organoid fabrication, flow cytometry, and transcriptomic data analysis.
The Feinberg School of Medicine is one of the top-ranked medical research institutions in the United States, and is known for its focus on patient-oriented biomedical research and clinical excellence. The laboratory is located in the heart of downtown Chicago. Salary and benefits are competitive.
Minimum Qualifications
They seek a highly motivated investigator with a PhD or MD degree, a strong background in cellular immunology and cell biology, and who is a self-starter, strong communicator, and problem solver.
Minimum Competencies
Applicants with experience in cell culture, molecular biology, mouse experimentation, flow cytometry, and big data are preferred.
Candidates should have excellent spoken and written communication skills command of the English language, and must be eligible to work in the US.
Contact
Interested applicants should send a cover letter describing qualifications and relevant work experience (maximum of 1 page), curriculum vitae and the names, telephone numbers and e-mail addresses of three references by e-mail to rheumatology@northwestern.edu with the subject line ‘Scleroderma Postdoctoral Scholar.’
Northwestern University is an Equal Opportunity, Affirmative Action Employer. Members of historically underrepresented groups are strongly encouraged to apply.